Wednesday, July 22, 2020

IEEE Spectrum: Handheld Vagus Nerve Stimulator Gets Emergency Approval for COVID-19 Use

Handheld Vagus Nerve Stimulator Gets Emergency Approval for COVID-19 Use
By Samuel K. Moore. 22 Jul 2020 | 16:30 GMT

The U.S. Food and Drug Administration has granted an emergency use authorization for treating suspected COVID-19 patients with a non-invasive vagus nerve stimulator. The handheld device, made by electroCore, in Basking Ridge, N.J., sends a train of electric pulses through the skin to a nerve in the neck. Research has shown this pulse train causes airways in the lungs to open and may also have a more general anti-inflammatory effect.

According to FDA’s authorization, the gammaCore Sapphire CV device can be used either at home or in a clinic or hospital to “acutely treat adult patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related [shortness of breath] and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief.”

This is a really cool piece of tech. Now I wonder how many different conditions this device might be able to treat using different frequencies and power levels.

No comments: